2006 News Archive


11/13/2006 Adherex Reports Third Quarter 2006 Financial Results
11/9/2006 Preclinical Data on Adherex's ADH-1 in Combination with Chemotherapy Presented at 18th EORTC-NCI-AACR Symposium Conference In Prague
11/8/2006 Clinical Data from Adherex's Proof-of-Mechanism and Phase I Eniluracil Trials to be Presented at November 8th Analyst and Investor Meeting
11/3/2006 Adherex to Present at Rodman & Renshaw 8th Annual Healthcare Conference
10/30/2006 Adherex Enters Into Agreement With International Childhood Liver Tumour Strategy Group (SIOPEL) For Conduct of Phase III Trial of STS
10/12/2006 Adherex to Hold Corporate Update Conference Call Today
10/11/2006 Adherex Regains All Rights to ADH-1
10/3/2006 Adherex Initiates Clinical Trial Program for ADH-1 in Combination with Chemotherapy
9/28/2006 Adherex Initiates Asian Phase I/II Trial of Eniluracil in Liver Cancer
9/18/2006 Corporate Growth Expert Michael Martin Joins Adherex Board of Directors
8/9/2006 Adherex Reports Second Quarter 2006 Financial Results
8/2/2006 Adherex to Hold 2Q06 Financial Results Conference Call on Aug. 10, 2006
6/5/2006 Adherex to Present Final ADH-1 Phase I Data at ASCO 2006 Annual Meeting
6/4/2006 Data To Be Presented on Adherex's Eniluracil at ASCO 2006 Annual Meeting
6/3/2006 Adherex Presents Phase IB Data From European ADH-1 Trial at ASCO 2006 Annual Meeting
5/15/2006 Adherex Reports First Quarter 2006 Financial Results
5/8/2006 Adherex Announces Closing of US$6.5 Million Private Placement
5/4/2006 Adherex Announces US$6.5 Million Private Placement
5/3/2006 Adherex Concludes Phase Ib Component of European ADH-1 Trial
4/26/2006 Adherex Initiates Proof-of-Mechanism Trial of Eniluracil
4/5/2006 Adherex Executes Clinical Trial Agreement for ADH-1 with the NCI
4/3/2006 Adherex Announces Presentations on ADH-1 and Eniluracil at 2006 AACR Annual Meeting
3/31/2006 Adherex Announces 2005 Fiscal Results
3/28/2006 Adherex Receives Regulatory Clearance for Phase II Weekly Dosing Schedule
3/2/2006 Adherex Expands Phase II ADH-1 Trial To Include Three Additional Canadian Sites
2/13/2006 Adherex CEO A Panelist At BIO CEO & Investor Conference
1/23/2006 5-FU Expert Presents Data Supporting Adherex's Approach to Development of Eniluracil
1/11/2006 Adherex Announces Corporate Goals for 2006
1/4/2006 Adherex Activates Phase I Trial of Eniluracil